Search - tctmd.com

Displaying 821 - 840 of 1181

Sort: Relevancy | Date

Presentation TVT 2022

The Future of Balloon-Expandable TAVR: SAPIEN X4 and the ALLIANCE Trial

Presenter: Tamim M. Nazif

June 08, 2022

Presentation TVT 2022

Current and Future Standards for THV and Delivery System Platforms

Presenter: Rahul Sharma

June 08, 2022

Presentation TVT 2022

Patient Selection, Technical Considerations, and Clinical Outcomes

Presenter: Anita W. Asgar

June 08, 2022

Presentation TVT 2022

Shared Decision-making: How Should the Heart Team Approach PMR Patients in the Gray Zone of Risk and Anatomy?

Presenter: Megan Coylewright

June 08, 2022

Presentation TVT 2022

Patient Selection Is the Key! Defining the Green and Yellow "Light Zones" for Mitral TEER: Are They Immutable?

Presenter: D. Scott Lim

June 08, 2022

Presentation TVT 2022

Clinician Expectations: Implications of Residual MR Post Mitral Valve Repair – Surgery vs TEER

Presenter: Allan Schwartz

June 08, 2022

Presentation TVT 2022

Redefining the Future of Aortic Stenosis: Diagnosis, Classification, and Management

Presenter: Martin Leon

June 08, 2022

Presentation TVT 2022

My Step-by-step Intraprocedural Imaging Strategy for TEER: Barlow, Flail, and MAC

Presenter: Eustachio Agricola

June 08, 2022

Presentation TVT 2022

Moderate AS With Evidence of Cardiac Damage: The PROGRESS Trial

Presenter: Philippe Genereux

June 08, 2022

Presentation TVT 2022

Transcatheter tricuspid repair with the PASCAL system: 30-day outcomes of the TriCLASP post-market study

Presenter: William Gray

June 08, 2022

Presentation TVT 2022

MR Is MR, Stop Making It So Complex

Presenter: Mani A. Vannan

June 08, 2022

Presentation TVT 2022

Moderate AS With Heart Failure: Updates and Lessons From TAVR UNLOAD

Presenter: Nicolas Van Mieghem

June 08, 2022

Presentation TVT 2022

Analysis of tricuspid valve morphologies which were deemed to be unsuitable for transcatheter tricuspid valve treatment

Presenter: Muhammed Gerçek

June 08, 2022

Presentation TVT 2022

Disproportionate MR Is the Key: Integrating Anatomy and Physiology

Presenter: Anna Sannino

June 08, 2022

Presentation TVT 2022

Severe AS With No Symptoms: Updates From Surgical Trials, EARLY TAVR, and EVOLVE

Presenter: Mark Russo

June 08, 2022

Presentation TVT 2022

Exercise Testing in Patients with Tricuspid Regurgitation Undergoing Transcatheter Tricuspid Valve Intervention

Presenter: Muhammed Gerçek

June 08, 2022

Presentation TVT 2022

Severe TR in the Setting of Advanced RV Dysfunction (Case-based)

Presenter: Edwin Ho

June 08, 2022

Presentation TVT 2022

Case-based Risk Stratification: Bridge too Far – Role of Multi-modality Assessment for Patient Selection

Presenter: Joao Cavalcante

June 08, 2022

Presentation TVT 2022

Clinical Impact of Device Lead Extraction in Severe Tricuspid Regurgitation

Presenter: Hirotomo Sato

June 08, 2022

Presentation TVT 2022

Tailoring TEER: Imaging for Clip Selection

Presenter: Fabien Praz

June 08, 2022

Advertisement

The Future of Balloon-Expandable TAVR: SAPIEN X4 and the ALLIANCE Trial

Current and Future Standards for THV and Delivery System Platforms

Patient Selection, Technical Considerations, and Clinical Outcomes

Shared Decision-making: How Should the Heart Team Approach PMR Patients in the Gray Zone of Risk and Anatomy?

Patient Selection Is the Key! Defining the Green and Yellow "Light Zones" for Mitral TEER: Are They Immutable?

Clinician Expectations: Implications of Residual MR Post Mitral Valve Repair – Surgery vs TEER

Redefining the Future of Aortic Stenosis: Diagnosis, Classification, and Management

My Step-by-step Intraprocedural Imaging Strategy for TEER: Barlow, Flail, and MAC

Moderate AS With Evidence of Cardiac Damage: The PROGRESS Trial

Transcatheter tricuspid repair with the PASCAL system: 30-day outcomes of the TriCLASP post-market study

MR Is MR, Stop Making It So Complex

Moderate AS With Heart Failure: Updates and Lessons From TAVR UNLOAD

Analysis of tricuspid valve morphologies which were deemed to be unsuitable for transcatheter tricuspid valve treatment

Disproportionate MR Is the Key: Integrating Anatomy and Physiology

Severe AS With No Symptoms: Updates From Surgical Trials, EARLY TAVR, and EVOLVE

Exercise Testing in Patients with Tricuspid Regurgitation Undergoing Transcatheter Tricuspid Valve Intervention

Severe TR in the Setting of Advanced RV Dysfunction (Case-based)

Case-based Risk Stratification: Bridge too Far – Role of Multi-modality Assessment for Patient Selection

Clinical Impact of Device Lead Extraction in Severe Tricuspid Regurgitation

Tailoring TEER: Imaging for Clip Selection

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content